Drug Trial Radar · NCT02872701
OTL38 Injection for Intraoperative Imaging of Folate Receptor Positive Lung Nodules
Last checked: Nov 19, 2026Latest source record: Mar 24, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
100
Actual
Start
May 4, 2017
Primary completion
Oct 31, 2018
Study completion Nov 30, 2018
Sponsor
- Lead sponsor
- On Target Laboratories, LLCIndustry
- Sponsor type
- Industry
- Collaborators
- Medelis Inc.
- First posted
- Aug 19, 2016
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Diagnostic
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 85 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a phase 2, multi-center, single dose, open-label, exploratory study in suspected lung cancer patients scheduled to undergo endoscopic or thoracic surgery per CT/positron emission tomography imaging based on standard of care. This study aims to assess the efficacy of OTL38 and Near Infrared Imaging (NIR) at identifying pulmonary nodules within the operating theater, and to assess the safety and tolerability of single intravenous doses of OTL38.
Conditions
- Lung Neoplasms
- Lung Cancer
Interventions
OTL38 for InjectionDrug
Folate analog ligand conjugated with an indole cyanine-like green dye as a solution in vials containing 3 mL at 2 mg/mL
Near infrared camera imaging systemDevice
Near infrared camera imaging system
Endoscopic or Thoracic SurgeryProcedure
Endoscopic or Thoracic Surgery
Primary outcomes
What the sponsor says the trial is designed to measure.
- Sensitivity or True Positive Rate (TPR)Time frame: 1 day
- False Positive Rate (FPR)Time frame: 1 day
Locations
6 sites in 2 countries. Site status is shown where the registry gives one.
Beth Israel Deaconess Medical Center
Boston, Massachusetts
Cleveland Clinic
Cleveland, Ohio
University of Pennsylvania
Philadelphia, Pennsylvania
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania
MD Anderson Cancer Center
Houston, Texas
Leiden University Medical Center
Leiden, Netherlands
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.